Ausgabe 6/2022
Inhalt (17 Artikel)
Should routine risk reduction procedures for the prevention and control of pandemics become a standard in all oncological outpatient clinics? The prospective COVID-19 cohort study: protect-CoV
Theres Fey, Nicole Erickson, Arndt Stahler, Maximilian Muenchhoff, Oliver T. Keppler, Katharina Ruehlmann, Gabriele Krauss-Pfeiffer, Hannah Steinberg, Alexander Graf, Stefan Krebs, Helmut Blum, Elham Khatamzas, Sarah Seynstahl, Jozefina Casuscelli, Daniel Markwardt, Roswitha Forstpointner, Timo Schinköthe, Michael von Bergwelt-Baildon, Volker Heinemann
Inhibition of DDX3 and COX-2 by forskolin and evaluation of anti-proliferative, pro-apoptotic effects on cervical cancer cells: molecular modelling and in vitro approaches
Doneti Ravinder, Shailima Rampogu, Gangappa Dharmapuri, Akbar Pasha, Keun Woo Lee, Smita C. Pawar
Interim analysis of companion, prospective, phase II, clinical trials assessing the efficacy and safety of multi-modal total eradication therapy in men with synchronous oligometastatic prostate cancer
Diane K. Reyes, Bruce J. Trock, Phuoc T. Tran, Christian P. Pavlovich, Curtiland Deville, Mohamad E. Allaf, Stephen C. Greco, Daniel Y. Song, Trinity J. Bivalacqua, Misop Han, Alan W. Partin, A. Oliver Sartor, Steven P. Rowe, Kenneth J. Pienta
ERBB2 S310F mutation independently activates PI3K/AKT and MAPK pathways through homodimers to contribute gallbladder carcinoma growth
Kun Fan, Jiwen Wang, Sheng Shen, Xiaojian Ni, Zijun Gong, Bohao Zheng, Wentao Sun, Tao Suo, Han liu, Xiaoling Ni, Houbao Liu
Mutation in SF3B1 gene promotes formation of polyploid giant cells in Leukemia cells
Sanjay Mukherjee, Abdullah Mahmood Ali, Vundavalli V. Murty, Azra Raza
Effects of an enteral nutrient-rich therapy with omega-3 fatty acids in patients with unresectable or recurrent biliary tract cancer or pancreatic cancer during chemotherapy: a case–control study
Kyohei Abe, Tadashi Uwagawa, Ryoga Hamura, Yoshihiro Shirai, Jungo Yasuda, Kenei Furukawa, Hironori Shiozaki, Shinji Onda, Takeshi Gocho, Toru Ikegami
KRT15 promotes colorectal cancer cell migration and invasion through β-catenin/MMP-7 signaling pathway
Weida Chen, Chengli Miao
ENO3 promotes colorectal cancer progression by enhancing cell glycolysis
Jingyu Chen, Zizhen Zhang, Jiaojiao Ni, Jiawei Sun, Fangyu Ju, Zhuo Wang, Liangjing Wang, Meng Xue
Optimized flow cytometric detection of transient receptor potential vanilloid-1 (TRPV1) in human hematological malignancies
Sofia A. Omari, Dominic P. Geraghty, Alhossain A. Khalafallah, Pooja Venkat, Yvette M. Shegog, Scott J. Ragg, Charles E. de Bock, Murray J. Adams
Chidamide augment sorafenib-derived anti-tumor activities in human osteosarcoma cells lines and xenograft mouse model
Ying Yuan, Daifeng Li, Xiang Hu, Yizhou Li, Wanrong Yi, Pengcheng Li, Yong Zhao, Zonghuan Li, Aiming Yu, Chao Jian, Aixi Yu
Evidence of a role for interleukin-6 in anoikis resistance in oral squamous cell carcinoma
Marilena Karavyraki, Richard K. Porter
The role of miR-153 and related upstream/downstream pathways in cancers: from a potential biomarker to treatment of tumor resistance and a therapeutic target
Vahab Alamdari-Palangi, Khojaste Rahimi Jaberi, Abbas Rahimi Jaberi, Seyed Mohammad Gheibihayat, Majid Akbarzadeh, Amir Tajbakhsh, Amir Savardashtaki
Cyclin-dependent kinases in breast cancer: expression pattern and therapeutic implications
Shazia Sofi, Umar Mehraj, Hina Qayoom, Shariqa Aisha, Syed Mohammad Basheeruddin Asdaq, Abdullah Almilaibary, Manzoor A. Mir
Controversy of tissue-agnostic approvals in immunotherapy and targeted therapy
Chinmoy K. Bose
Photodynamic therapy using mannose-conjugated chlorin e6 increases cell surface calreticulin in cancer cells and promotes macrophage phagocytosis
Yuka Kimura, Hiromasa Aoki, Tatsuki Soyama, Akira Sakuragi, Yuto Otsuka, Akihiro Nomoto, Shigenobu Yano, Hirotada Nishie, Hiromi Kataoka, Mineyoshi Aoyama
Unique combinations of epigenetic modifiers synergistically impair the viability of the U87 glioblastoma cell line while exhibiting minor or moderate effects on normal stem cell growth
Arshak R. Alexanian, Avonlea Brannon